
Mineralys Therapeutics, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€0.00 - Gross profit
€0.00 - SG&A expenses
€24.33M - R&D expenses
€149.90M - EBITDA
-€174.21M - D&A
€22.31K - EBIT
-€174.23M - Interest expenses
€0.00 - EBT
-€163.68M - Tax expenses
€0.00 - Net income
-€163.68M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€26.47M - Changes in working capital
-€37.08M - Operating cash flow
-€165.32M - Capex
€31.75K - Other investing cash flow
€0.00 - Net investing cash flow
€23.52M - Total cash dividends paid
€0.00 - Issuance of common stock
€162.06M - Debt repayment
€0.00 - Other financing cash flow
€8.61M - Net financing cash flow
€170.91M - Foreign exchange effects
€0.00 - Net change in cash
€29.11M - Cash at end of period
€87.33M - Free cash flow
-€165.29M
Balance sheet
- Cash and cash equivalents
€87.33M - Cash and short-term investments
€87.33M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€200.33M - Total current assets
€287.66M - Property, plant & equipment
€18.88K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€371.51K - Total non-current assets
€390.39K - Total assets
€288.05M - Accounts payable
€2.71M - Short-term debt
€0.00 - Other current liabilities
€16.31M - Total current liabilities
€19.02M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€0.00 - Total liabilities
€19.02M - Common stock
€5.15K - Retained earnings
-€332.91M - Other equity
€0.00 - Total equity
€269.03M - Total liabilities and shareholders' equity
€288.05M
Company information
- Market capitalization
€762.16M - Employees
51 - Enterprise Value
€848.47M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-60.8% - ROA
-
-56.8% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-21.7% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€3.21M